Acro Biomedical (ACBM) Receivables - Other (2019)

Acro Biomedical (ACBM) recorded quarterly Receivables - Other of $45000.0 in Q3 2019, up 125.0% quarter-over-quarter from $20000.0 in Q2 2019.

Acro Biomedical (ACBM) Receivables - Other (2019) Analysis & Trends

Acro Biomedical's Receivables - Other history runs 1 years deep, the most recent figure standing at $45000.0 for Q3 2019.

In Q3 2019, Receivables - Other changed N/A year-over-year to $45000.0; the TTM figure through Sep 2019 stood at $45000.0 (changed N/A YoY), while the FY2019 annual figure was $45000.0, changed N/A from the prior year.
Receivables - Other was $45000.0 for Q3 2019 at Acro Biomedical, up from $20000.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $45000.0 in Q3 2019 to a low of $20000.0 in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	EQV Ventures Acquisition	477.93 Mn	477.93 Mn	-
2	GP-Act III Acquisition	312.80 Mn	312.80 Mn	-
3	Berto Acquisition	311.56 Mn	311.56 Mn	-
4	Churchill Capital Corp IX	310.79 Mn	310.79 Mn	-
5	Centurion Acquisition	310.21 Mn	310.21 Mn	-
6	WEN Acquisition	309.15 Mn	309.15 Mn	-
7	Agriculture & Natural Solutions Acquisition	303.81 Mn	303.81 Mn	-
8	Bold Eagle Acquisition	274.64 Mn	274.64 Mn	-
9	Live Oak Acquisition Corp. V	265.88 Mn	265.88 Mn	-
10	Acro Biomedical	-	-	-

Download Data